Cleft Lip and PalateNCT03217890
the Relationship Between Cleft Lip and / or Palate (Different Types) and ABO Blood Groups.
An observational study of Cleft Lip and Palate, run by Cairo University.
Trial summary
Direct benefit of the research to assess the relationship between cleft lip and / or palate (different types) and ABO blood groups. Read more about this study
- Who is it for?
- Ages 2 days to 15 years
- Conditions the study is for
- Cleft Lip and Palate
- How many people
- 376 participants
- Where
- No sites listed yet
- Study dates
- Aug 2017to Aug 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 days to 15 years
- All sexes
- No healthy volunteers
- Child
Study population: 376 Egyptian cleft lip and/or palate patients (Age ranged from 2 days to 15 years ) With no syndrome .
Who may be able to join
- Egyptian Patients with cleft or/and palate
- The children's age ranged between 2 days and 15 years.
Who cannot join
- syndromic patients
About this study
Official title: Distribution Of ABO Blood Groups In Relation To Cleft Lip And/or Palate .
Direct benefit of the research to assess the relationship between cleft lip and / or palate (different types) and ABO blood groups.
Read the detailed description
376 Egyptian cleft lip and/or palate patients ( age ranged from 2 days to 15 years ) With no syndrome. Blood group from records will be collected an d then assess the relationship between cleft lip and / or palate (different types) and ABO blood groups.
- Conditions
- Cleft Lip and Palate
- Medical subject headings
- Cleft Lip
What is being measured
The primary outcome is the main question the study is designed to answer.
Distribution of ABO blood group in relation to different types of cleft lip and/or palate .
ABO blood group
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jul 2017
- Study startAug 2017 (estimated)
- Primary completionAug 2017 (estimated)
- Study completionAug 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cleft Lip and PalateStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 376 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mostafa medhat helmy, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03217890
- Sponsor's protocol ID
- CEBC-CU-2017-07-18
- Status last verified
- Jul 2017
- First submitted
- 11 Jul 2017
- Last updated
- 14 Jul 2017
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 14 Jul 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Distribution Of ABO Blood Groups In Relation To Cleft Lip And/or Palate .
- ClinicalTrials.gov ID
- NCT03217890
- Acronym / sponsor ID
- CEBC-CU-2017-07-18
- Conditions
- Cleft Lip and Palate
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 376 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- Aug 2017 (estimated)
- Primary completion
- Aug 2017 (estimated)
- Study completion
- Aug 2017 (estimated)
- First posted
- 14 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Direct benefit of the research to assess the relationship between cleft lip and / or palate (different types) and ABO blood groups.
Detailed description
376 Egyptian cleft lip and/or palate patients ( age ranged from 2 days to 15 years ) With no syndrome. Blood group from records will be collected an d then assess the relationship between cleft lip and / or palate (different types) and ABO blood groups.
Study design
- Observational model
- Other
- Time perspective
- Other
Who may qualify
- Ages
- 2 days to 15 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- 376 Egyptian cleft lip and/or palate patients (Age ranged from 2 days to 15 years ) With no syndrome .
Key inclusion criteria (2 listed)
- Egyptian Patients with cleft or/and palate
- The children's age ranged between 2 days and 15 years.
Key exclusion criteria (1 listed)
- syndromic patients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Distribution of ABO blood group in relation to different types of cleft lip and/or palate .
Time frame: 6 months
ABO blood group
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jul 2017.
- Individual participant dataSharing planned: Undecided
Related trials for Cleft Lip and Palate
Not yet recruiting
Comparative Study of Regional Nerve Blocks in Primary Cleft Palate Repair
Cleft Lip, Cleft Palate +/- Lip
Not yet recruiting
Quadratus Lumborum Block for Iliac Bone Harvest in Pediatric Cleft Alveolus Repair
Cleft Lip Palate
RecruitingObservational study
Perceptions of High and Low Intensity Speech Intervention in Children With a Cleft Palate
Cleft Lip and Palate, Cleft Palate Children
Not yet recruitingPhase 3
Safety and Efficacy of Bone Bioengineering Kit With Stem Cells for Alveolar Cleft Repair
Cleft Lip Palate
Enrolling by invitation
Speech Intervention Frameworks in Cantonese-speaking Children and Adolescences With Cleft Palate +/- Lip
Cleft Palate +/- Lip
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Cleft Lip and Palate, run by Cairo University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Distribution of ABO blood group in relation to different types of cleft lip and/or palate . (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2017.